Atlas Trials

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

Clinical trial NCT03849365 · TERMINATED

Trial details

NCT number
NCT03849365
Sponsor
Steba Biotech S.A.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Low Risk Prostate Cancer
Start date
2019-01-21
Primary completion
2020-11-13
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.